Chromatography Forum of the Delaware Valley – Dal Nogare Award
Dr. Irving W. Wainer of the National Institutes of Health will receive the 2013 Dal Nogare award this morning presented by the Chromatography Forum of the Delaware Valley.
Session 250, 8:00 am
Room 126A
Dr. Irving W. Wainer of the National Institutes of Health will receive the 2013 Dal Nogare award this morning presented by the Chromatography Forum of the Delaware Valley. The Dal Nogare awardee is chosen on the basis of his or her contributions to the fundamental understanding of the chromatographic process.
Dr. Wainer has a wide range of scientific accomplishments, specifically, in the area of effect of disease state on drug metabolism. Wainer and his group identified a number of discordances between metabolic genotype and expressed phenotype in patients with advanced cancer and aids. In the area of immobilized receptors, transporters, and enzymes, Wainer developed liquid chromatographic stationary phases containing immobilized receptors, enzymes, and transporters as an on-line, flow system for use in drug discovery and in the characterization of lead drug candidates. A wide variety of new and unique bioanalytical methods for the quantification of drugs in biological matrices were developed in the Wainer group. These methods have been applied to pharmokinetic and clinical studies.
The Complexity of Oligonucleotide Separations
January 9th 2025Peter Pellegrinelli, Applications Specialist at Advanced Materials Technology (AMT) explains the complexity of oligonucleotide separations due to the unique chemical properties of these molecules. Issues such as varying length, sequence complexity, and hydrophilic-hydrophobic characteristics make efficient separations difficult. Separation scientists are addressing these challenges by modifying mobile phase compositions, using varying ion-pairing reagents, and exploring alternative separation modes like HILIC and ion-exchange chromatography. Due to these complexities, AMT has introduced the HALO® OLIGO column, which offers high-resolution, fast separations through its innovative Fused-Core® technology and high pH stability. Alongside explaining the new column, Peter looks to the future of these separations and what is next to come.
Metabolomics Analysis of Low Birth-Weight Infants Using UHPLC-MS/MS Following Lipid Emulsion
January 10th 2025A recent study aimed to directly compare the changes in serum metabolites among very low birth-rate (VLBW) infants following the administration of the soybean oil-based lipid emulsion and soybean oil, medium-chain triglycerides, olive oil, and fish oil (SMOF) lipid emulsion using untargeted metabolomics techniques.
Analyzing New Drug Modalities: An ISC 2024 Interview with Kelly Zhang
January 10th 2025At ISC 2024 in Liverpool, United Kingdom, LCGC International interviewed Kelly Zhang of Genentech about her work analyzing new drug modalities, such as mRNA, oligonucleotides, peptides, and cell and gene therapies.
